{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65"}]}],"title":"Achieved 5 x 10EE CD34 cells/kg"},{"categories":[{"measurements":[{"groupId":"OG000","value":"35"}]}],"title":"Did not achieve 5 x 10EE CD34 cells/kg"}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"}],"units":"Participants"}],"description":"Here is the percentage of patients that achieved or did not achieve 5 x 10\\^6 CD34 cells/kg in a single apheresis.","groups":[{"description":"Subjects will undergo mobilization and collection of HPC, Apheresis for subsequent use in various clinical protocols.\n\nFilgrastim: Filgrastim will be administered as a single daily dose in a dose range of 10-16ug/kg/day subcutaneously for 5-7days\n\nPlerixafor: Plerixafor will be given on day 4, 8-10 hours before the day 5 apheresis, dose calculated according to patient weight\n\nApheresis: The minimum cluster of differentiation 34 (CD34)+ cell dose that must be collected in order to proceed with a single autologous transplantation is 2 x 106 CD34+ cells/kg.","id":"OG000","title":"Hematopoietic Progenitor Cells"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Through Day 2 of collection","title":"Percentage of Patients That Achieved or Did Not Achieve 5 x 10^6 Cluster of Differentiation 34 (CD34) Cells/kg","type":"SECONDARY","unitOfMeasure":"percentage of patients"}